Viridian Therapeutics Inc (FRA:1S1)
€ 10.9 -0.2 (-1.8%) Market Cap: 713.31 Mil Enterprise Value: 352.93 Mil PE Ratio: 0 PB Ratio: 2.03 GF Score: 46/100

Viridian Therapeutics Inc (FRA:1S1) Transcripts

  • 1